Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Recruiting · NCT01954992 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Recruiting | Phase 3 | 2026-10-07 | NCT01954992 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eleison Pharmaceuticals LLC. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Gabrail Cancer Center Research | Canton | United States | 26 |
| Innovative Clinical Research Institute | Whittier | United States | 4 |
| Moffitt Cancer Center | Tampa | United States | 523 |